Immune drug-induced liver disease and drugs
Authors:
- James C. WaddingtonJames C. Waddington
- Xiaoli MengXiaoli Meng
- Dean J. NaisbittDNDean J. Naisbitt
- B. Kevin ParkBPB. Kevin Park
- 1 August 2018
- journal article
- Published by Elsevier in Current Opinion in Toxicology
- Vol. 10, 46-53
Abstract
No abstract availableFunding Information
- Medical Research Council Centre for Drug Safety Science (MR/L006758/1)
This publication has 60 references indexed in Scilit:
- From the Cover: Characterization of Isoniazid-Specific T-Cell Clones in Patients with anti-Tuberculosis Drug-Related Liver and Skin InjuryToxicological Sciences, 2016
- Characterization of amoxicillin‐ and clavulanic acid‐specific T cells in patients with amoxicillin‐clavulanate–induced liver injuryHepatology, 2015
- T Cells Infiltrate the Liver and Kill Hepatocytes in HLA-B∗57:01-Associated Floxacillin-Induced Liver InjuryThe American Journal of Pathology, 2014
- Detection of anti-isoniazid and anti–cytochrome P450 antibodies in patients with isoniazid-induced liver failureHepatology, 2013
- Pharmacogenomics of severe cutaneous adverse reactions and drug-induced liver injuryJournal of Human Genetics, 2013
- Human Leukocyte Antigen (HLA)-B*57:01-Restricted Activation of Drug-Specific T cells Provides the Immunological Basis for Flucloxacillin-Induced Liver InjuryHepatology, 2012
- Susceptibility to Amoxicillin-Clavulanate-Induced Liver Injury Is Influenced by Multiple HLA Class I and II AllelesGastroenterology, 2011
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillinNature Genetics, 2009
- Genome-wide pharmacogenetic investigation of a hepatic adverse event without clinical signs of immunopathology suggests an underlying immune pathogenesisThe Pharmacogenomics Journal, 2007
- Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case–control studyThe Pharmacogenomics Journal, 2007